Synergy CHC Corp (SNYR): Prakiraan gabungan firma investasi

Logo korporat perusahaan Synergy CHC Corporation (SNYR)

Synergy CHC Corp (SNYR) is scaling its wellness asset network through digital sales, leveraging the acquisition of profitable cosmetics brands that ensure a steady cash flow due to customer loyalty. This price chart reflects a current level of 3.76. However, the marketing environment is becoming more complex: customer acquisition costs are rising, and inflation within the DTC segment is triggering a partial churn of the audience.

SNYR Bagan rega target Synergy CHC Corp. (24.10.2024 - 03.10.2026)

Rincian analitis perusahaan Synergy CHC Corp (SNYR)

SNYR — sistem indikator bursa lan keuangan synergychc.com:
Analisis umum perusahaan:SNYR Synergy CHC Corp.
Barang unggulan Synergy CHC

Investors utilize this indicator to determine an asset's fair value based on aggregated fundamental models from professional analysts. The average target price, which forms the consensus target for the stock, reflects the growth potential of Synergy CHC Corp (SNYR), given the multi-profile holding's resilience driven by brand diversification within the beauty and health sector and omnichannel distribution.

Pesaing Synergy CHC Corp

Target median analis haleon.com|Bagan rega target Kenvue KVUE|VRNA: Prakiraan gabungan firma investasi|MENS: Target konsensus|Rata-rata rega prakiraan Ligand Corp|Amneal Pharmaceuticals (AMRX) - Bagan rega target|perrigo.com - Konsensus nilai wajar|Bagan rega target Alvotech SA|Liquidia Corp - Bagan tingkat prakiraan|Prakiraan konsensus analis GLPG|ANIP (ANI Pharmaceuticals Corp) - Konsensus nilai wajar|Prakiraan konsensus analis MNKD (MannKind Corporation)|Prakiraan konsensus analis amphastar.com AMPH|PCRX - Bagan rega target|Konsensus nilai wajar SPRY (ARS Pharmaceuticals Inc)|Theravance (TBPH) - Bagan rega target|Target konsensus Aquestive Corp|SCPH (scPharmaceuticals, Inc.) - Prakiraan konsensus analis|Prakiraan konsensus analis Tectonic|Target konsensus TNXP (Tonix Pharmaceuticals Holding Corp.)|SXTC (sxtchina.com) - Konsensus nilai wajar|Bagan rega target Eupraxia Pharmaceuticals Inc. EPRX|BioHarvest Sciences Inc (BHST) - Rata-rata rega prakiraan|EXOZ: Target konsensus|Oramed Pharmaceuticals - Rega prakiraan analis|ENTX: Prakiraan konsensus analis|MindWalk Holdings, Inc. - Konsensus nilai wajar|ABVC (ABVC BioPharma Inc) - Prakiraan konsensus analis|Rata-rata rega prakiraan Cumberland Corp CPIX|Bagan rega target Quantum BioPharma Ltd (QNTM)|FGEN (fibrogen.com) - Konsensus nilai wajar|Bagan rega target Telomir Pharmaceuticals, Inc. TELO|Target median analis Rani Therapeutics Holdings (RANI)|RLYB: Target konsensus|Rata-rata rega prakiraan Lexaria Bioscience|Pulmatrix, Inc. (PULM) - Bagan rega target|Prakiraan gabungan firma investasi PTHL|APM (Aptorum Group Ltd) - Prakiraan konsensus analis|Rata-rata rega prakiraan Lyra Therapeutics Inc. LYRA|Bagan rega target Impact BioMedical Inc (IBO)|TNFA (tnfpharma.com) - Konsensus nilai wajar|Prakiraan konsensus analis YCBD (cbdMD)|Rentang target analis painreform.com|CYTO: Target konsensus|Rata-rata rega prakiraan Lipella Pharmaceuticals Inc|OPTN (Optinose) - Target konsensus|Pieris Pharma - Konsensus nilai wajar|PROC (Procaps Group S.A.) - Prakiraan konsensus analis|Target konsensus petrospharma.com (PTPI)|Prakiraan konsensus analis QLI|SLRN (Acelyrin Inc.) - Konsensus nilai wajar|Prakiraan konsensus analis TFFP (TFF Pharma)